Professional Documents
Culture Documents
3rd Internal 2020 Batch (2nd Year)
3rd Internal 2020 Batch (2nd Year)
3rd Internal 2020 Batch (2nd Year)
Acute plaquechange.
e) Renal changes in SLE.
f) Hodgkin's lymphoma
g) Difference between Obstructive jaundice and Haemolytic jaundice
Urine
e45 year old male presented with polyuria, polydypsia and polyphagia.
Give your probable
examination revealed presence of reducing substances in urine.
Mention its diagnostic criteria.
diagnosis.
and complication.,
1 Define Bronchiectasis.
Describe
its pathogenesis, morphology
(2+5+3+2)
in kidney is seen in
d. Kimmelstiel Wilson lesion
ii) Diabetes mellitus
Renal cell carcinoma Amyloidosis
i)
iv) Hypertension
atherosclerosis
a modifiable risk factor for
e. The following is Male gender
ii) Increasing age iv)
Hypertension ii) Family history
choriocarcinoma is
Most useful tumor marker for
iv) CEA
i) CA-125 ii) AFP in)B-HCG
Nhat should be the possible clinical diagnosis? What is the organism causing the
clinieal condition?
How will you investigate in the laboratory to reach the correct diagnosis?
W h a t test you will carry out to monitor the efficacy of treatment?
P.T.
5. Ultra short notes: [1 markx5-5]
a. Name two fungi causing pneumonia
b. Name the organisms causing Infectious Mononucleosis
. Name two organisms which can be used as Bioterrorism agents
d. Name two parasites causing central nervous system intection
e. Name two laboratory tests used for diagnosis of Dengue fever
6. Fill in the blanks: [1mark x5-5]
a. - - .
i s the vectorfor Japanese encephalitis virus
b. ----
causes Tinea versicolor
C. - -
is caused by HHV8
d. ------
is the causative organism of Granuloma inguinale
e. Afla toxin is produced by
3rd Internal Pharmacology Question Paper
(
Department of Pharmacology, KIMS, BBSR
Use separate answer sheet for Sec-A & Sec-B
NSTIT MEO1c
Sec-A
Define Bioavailability. Mention different factors affecting bioavailability with
suitable examples. Draw a diagram to depict the bioavailability following oral
and IV route of administration. (2+9+4=15)
02. Answer short notes on: (5x6-30)
Sec-B
Clasify anti-malarial drugs. Mention the mechanism of action, therapeutic uses
and adverse drug reaction of Chloroquine. How will manage a case relapsing
malaria? (4+2+4+2+3=15)
Q2. Answer short notes on: (5x6-30)
Mechanism of action and therapeutic uses of Metformin.
b. Mechanism of action& disadvantages of Radioactive lodine.
List 4 antifungals.
k. List 4 conmon features of Aminoglycosides.
**